Shockwave therapy or solifenacin for overactive bladder in women
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial compares a new treatment (low-intensity shockwave therapy) with a standard medication (solifenacin) to see which works better for women with overactive bladder (OAB). Overactive bladder means you feel a sudden, strong need to urinate, often have to go frequently, or may leak urine. The study aims to find a more effective or better-tolerated option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had symptoms of overactive bladder for at least 3 months.
- Your symptoms are moderate to severe (based on a standard symptom score of 7 or higher).
- You are willing and able to give informed consent to participate.
- You do not have a current urinary tract infection.
- You have not used certain bladder medications (like anticholinergics or beta-3 agonists) in the past 4 weeks, or you are willing to stop them for the study.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two medications—tadalafil (a daily pill for blood flow) and solifenacin (a pill that relaxes the bladder)—to see which works better for women with overactive bladder (OAB), which causes sudden, strong urges to urinate. It will help doctors find a treatment that may have fewer side effects.
This study compares two pills (solifenacin and mirabegron) for treating overactive bladder. It aims to see which works better and has fewer side effects. You may qualify if you're newly diagnosed and haven't tried these medicines before.
This study compares different treatments for overactive bladder in women in Taiwan. It aims to find the best approach to help control symptoms like frequent or urgent urination.
This trial tests a new procedure that uses radiofrequency energy to calm the nerve responsible for overactive bladder in women. It aims to reduce urge-related urine leaks without surgery or medications.
This trial tests a prescription digital app to help women with overactive bladder (OAB) symptoms. It may be a good fit if you are a woman over 22 with bothersome OAB and are willing to use the app instead of other treatments for 8 weeks.
This trial tests a non-surgical device that uses mild electrical stimulation to treat overactive bladder. It may help if you have a sudden, strong need to pee often or wake up at night to pee.
Hear when a new Overactive Bladder (OAB) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.